San Diego, CA32 Active Studies

Essential Tremor Clinical Trials in San Diego, CA

Find 32 actively recruiting essential tremor clinical trials in San Diego, CA. Connect with local research sites and explore new treatment options.

32
Active Trials
26
Sponsors
124,780
Enrolling

Recruiting Essential Tremor Studies in San Diego

About Essential Tremor Clinical Trials in San Diego

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 32 essential tremor clinical trials recruiting participants in San Diego, CA. These studies are seeking a combined 124,780 participants. Research is being sponsored by Rady Pediatric Genomics & Systems Medicine Institute, VA Office of Research and Development, Sparrow Pharmaceuticals and 23 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in San Diego — FAQ

Are there essential tremor clinical trials in San Diego?

Yes, there are 32 essential tremor clinical trials currently recruiting in San Diego, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Diego?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.

Are clinical trials in San Diego free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 32 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 16, 2026 from ClinicalTrials.gov